CanaFarma Hemp Products Corp. (OTCPK: CNFH.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
CanaFarma Hemp Products Corp. (OTCPK: CNFH.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.19K.
trading between 0.00 and 0.00.
Tweenvest scores CanaFarma Hemp Products Corp. across four factors: quality 8/100, value 54/100. Its strongest factor is value.
CNFH.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.19K
- Revenue (TTM)
- $765.56K
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 35.63
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 218.91M
- Employees
- —
- Next earnings
- —
About CanaFarma Hemp Products Corp.
CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.
- Listed since
- Mar 19, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.